BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34515203)

  • 1. The Relationship between the Tissue Expression of TLR2, TLR4, TLR5, and TLR7 and Systemic Inflammatory Responses in Colorectal Cancer Patients.
    Beilmann-Lehtonen I; Hagström J; Kaprio T; Stenman UH; Strigård K; Palmqvist R; Gunnarsson U; Böckelman C; Haglund C
    Oncology; 2021; 99(12):790-801. PubMed ID: 34515203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
    Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
    PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Tissue TLR5 Expression Predicts Better Outcomes in Colorectal Cancer Patients.
    Beilmann-Lehtonen I; Hagström J; Mustonen H; Koskensalo S; Haglund C; Böckelman C
    Oncology; 2021; 99(9):589-600. PubMed ID: 34139707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
    Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
    BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.
    Beilmann-Lehtonen I; Böckelman C; Mustonen H; Koskensalo S; Hagström J; Haglund C
    Virchows Arch; 2020 Nov; 477(5):705-715. PubMed ID: 32424768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome.
    Kasurinen A; Hagström J; Laitinen A; Kokkola A; Böckelman C; Haglund C
    Sci Rep; 2019 Aug; 9(1):12553. PubMed ID: 31467388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome.
    Paarnio K; Tuomisto A; Väyrynen SA; Väyrynen JP; Klintrup K; Ohtonen P; Mäkinen MJ; Mäkelä J; Karttunen TJ
    APMIS; 2019 Aug; 127(8):561-569. PubMed ID: 31132191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer.
    Paarnio K; Väyrynen S; Klintrup K; Ohtonen P; Mäkinen MJ; Mäkelä J; Karttunen TJ
    World J Gastroenterol; 2017 Jul; 23(26):4831-4838. PubMed ID: 28765705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of Toll‑like receptors in human breast cancer.
    Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
    Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
    Lanki M; Seppänen H; Mustonen H; Hagström J; Haglund C
    PLoS One; 2019; 14(7):e0219245. PubMed ID: 31314777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.
    Sánchez-Muñoz F; Fonseca-Camarillo G; Villeda-Ramírez MA; Miranda-Pérez E; Mendivil EJ; Barreto-Zúñiga R; Uribe M; Bojalil R; Domínguez-López A; Yamamoto-Furusho JK
    BMC Gastroenterol; 2011 Dec; 11():138. PubMed ID: 22185629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and localization of Toll-like receptors 2, 4, 5 and 9 in the epididymis and vas deferens of a adult tom cats.
    Liman N; Alan E; Apaydın N
    Theriogenology; 2019 Apr; 128():62-73. PubMed ID: 30743105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
    Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
    World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.
    Wang EL; Qian ZR; Nakasono M; Tanahashi T; Yoshimoto K; Bando Y; Kudo E; Shimada M; Sano T
    Br J Cancer; 2010 Mar; 102(5):908-15. PubMed ID: 20145615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia.
    Pimentel-Nunes P; Afonso L; Lopes P; Roncon-Albuquerque R; Gonçalves N; Henrique R; Moreira-Dias L; Leite-Moreira AF; Dinis-Ribeiro M
    Pathol Oncol Res; 2011 Sep; 17(3):677-83. PubMed ID: 21455638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy.
    Nurmi AM; Hagström J; Mustonen H; Seppänen H; Haglund C
    PLoS One; 2022; 17(5):e0267792. PubMed ID: 35536778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
    Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
    Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of Toll-like receptor-2, -4, -5, -7 and NOD2 stimulation on Na
    Cosme D; Soares-da-Silva P; Magro F
    Am J Physiol Cell Physiol; 2023 May; 324(5):C1028-C1038. PubMed ID: 36847442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.